from the 6-23 Edison Report
While Kazia has fully funded the ongoing Phase IIa study of GDC-0084 in GBM, it would require additional funds of ~A$15–20m for a Phase IIb trial, which could result in significant dilution of existing shareholders.
- Forums
- ASX - By Stock
- Share Price
from the 6-23 Edison ReportWhile Kazia has fully funded the...
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)